Wockhardt informs about outcome of board meeting

07 Nov 2019 Evaluate

Wockhardt has informed that pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations’) read with Schedule III of Listing Regulations, the Company enclosed Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2019, as approved by the Board of Directors at its meeting held today; and Limited Review Report issued by BSR & Co. LLP., Statutory Auditors of the Company. Also enclosed herewith copy of the Press Release proposed to be issued in respect of the said Financial Results; and extract of Unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2019, being published in the Newspapers. The Board Meeting commenced at 2.15 pm and concluded at 3.30 pm.

The above information is a part of company’s filings submitted to BSE.

Wockhardt Share Price

1360.10 28.75 (2.16%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×